Exponent
EXPO Nasdaq· Research & Consulting Services
Last close · Oct 26, 2026
$77.66
KIRA · Stoqly’s AI analyst, in plain words
- Exponent had $582M of revenue in fiscal 2025, up 4.2% on the year before. Over five years, revenue changed +7.8% a year on average.
- Its operating margin was 20.6%, down 0.8 pts: of every 100 in sales, about 21 is left after running the business.
- Exponent made $106M of net profit in fiscal 2025. From fiscal 2016 to 2025, diluted EPS grew 10.1% a year.
- Free cash flow was $122M in fiscal 2025, 21.0% of revenue.
- Exponent returned $158M to shareholders in fiscal 2025, 129% of free cash flow. The diluted share count fell 0.6%.
- Exponent has $222M more cash than debt.
Market cap
$3.8B
P/E
34.8x
Revenue
$582M
Net income
$106M
Free cash flow
$122M
Operating margin
20.6%
Exponent in 30 seconds · fiscal 2025
Are sales growing?
+4.2%
Only a little. Sales grew 4.2% last year.
Does it make a profit?
18.2%
Yes. It keeps 18.2% of every sale as profit.
Does profit turn into cash?
21.0%
Yes. 21.0% of sales ends up as free cash.
Is debt under control?
Net cash
Yes. It has more cash than debt.
How healthy are the accounts?
4 / 8
Mixed. It passes 4 of 8 health tests.
How is the share priced?
34.8x
One share costs 34.8 times its yearly profit per share. Typical for its sector: 26.0x.
What Exponent does
No business description yet.
- Fiscal year ends
- January 2, 2026
- Latest annual report
- 10-K · Feb 27, 2026
- Legal name
- EXPONENT, INC.
- CIK
- 0000851520
Exponent · EXPO
Results and finances
The last 5 fiscal years. Amounts in USD.
| Fiscal year | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Sales and profit | |||||
| Revenue | $466M | $513M | $537M | $559M | $582M |
| Revenue growth | 16.6% | 10.1% | 4.6% | 4.1% | 4.2% |
| Operating margin | 23.4% | 27.4% | 20.7% | 21.4% | 20.6% |
| Net income | $101M | $102M | $100M | $109M | $106M |
| Net margin | 21.7% | 19.9% | 18.7% | 19.5% | 18.2% |
| Diluted EPS | $1.90 | $1.96 | $1.94 | $2.11 | $2.07 |
| Cash | |||||
| Cash from operations | $125M | $93.8M | $127M | $145M | $132M |
| Capital expenditure | $6.8M | $12.0M | $16.4M | $6.9M | $9.4M |
| Free cash flow | $118M | $81.8M | $111M | $138M | $122M |
| FCF margin | 25.3% | 15.9% | 20.7% | 24.6% | 21.0% |
| Dividends paid | $41.7M | $49.1M | $52.7M | $56.8M | $60.4M |
| Share buybacks | $7.0M | $156M | $24.2M | $5.7M | $97.1M |
| Share count change | 0.0% | −2.0% | −1.2% | −0.1% | −0.6% |
| Debt and strength | |||||
| Cash and short-term investments | $298M | $162M | $187M | $259M | $222M |
| Debt incl. finance leases | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M |
| Shareholders' equity | $417M | $321M | $356M | $421M | $390M |
| Net debt / EBITDA | −2.6x | −1.1x | −1.6x | −2.0x | −1.7x |
| Current ratio | 3.0x | 2.2x | 2.3x | 2.7x | 2.4x |
| Returns and quality | |||||
| Return on capital | 73.5% | 78.2% | 50.1% | 53.4% | 52.2% |
| Return on equity | 26.0% | 27.7% | 29.7% | 28.1% | 26.1% |
| Piotroski F-score | 5 | 3 | 7 | 5 | 4 |
| Altman Z'' | 7.9 | 7.9 | 7.5 | 7.3 | 7.0 |
Insiders bought, 12 months
$0.0M
1 insider
Insiders sold, 12 months
$3.0M
6 insiders
Of sales under plans
73%
$2.2M
How to read these numbers
- Revenue:
- Total sales reported in the income statement.
- Operating margin:
- Operating income as a share of revenue.
- Net income:
- Profit after all expenses, interest and tax.
- Free cash flow:
- Cash from operations minus capital spending.
- Net debt / EBITDA:
- Years of EBITDA needed to pay off net debt. Below zero means more cash than debt.
- Return on capital:
- After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Exponent · EXPO
Charts and comparison
Ten years at a glance, and how it stacks up against similar companies.
Revenue
Net income
Margins, % of revenue
Cash vs debt (incl. leases)
Free cash flow
Dividends and buybacks
Similar companies
Each company’s latest fiscal year. Fiscal years end in different months, so periods don’t line up exactly.
| Company | Market cap | Growth | Op. margin | FCF margin | ROIC | P/E | F-score |
|---|---|---|---|---|---|---|---|
| Exponent EXPO | $3.8B | 4.2% | 20.6% | 21.0% | 52.2% | 34.8x | 4 |
| UL Solutions ULS | $14.9B | 6.4% | 17.1% | 13.2% | 26.8% | 29.4x | 7 |
| Verisk Analytics VRSK | $26.5B | 6.6% | 43.7% | 38.8% | 35.5% | 29.9x | 7 |
| FTI Consulting FCN | $4.7B | 2.4% | 10.3% | 2.5% | 16.6% | 19.4x | 4 |
| TransUnion TRU | $15.5B | 9.4% | 18.7% | 14.5% | 7.1% | 22.1x | 8 |
Price compared with profit (P/E)
How many times its yearly profit per share one share costs. Higher means investors pay more for each unit of profit.
KIRA
At $77.66 a share, the company is worth $3.8B: 34.8 times its earnings of the last four quarters.
Exponent grew sales faster than 1 of its 4 similar companies. Its P/E is higher than 4 of 4.
Source: SEC EDGAR XBRL filings (CIK 0000851520). Data updated October 16, 2026. For information only — not investment advice. Check the original filings before relying on any figure.